TSXV:TRL.H - Post by User
Comment by
Tornado71on Mar 21, 2018 10:17am
136 Views
Post# 27752699
RE:RE:RE:RE:Mackie Research Report ASP
RE:RE:RE:RE:Mackie Research Report ASPThis is from Capital Ideas Research:
"Acerus Pharma (ASP-T) Mackie Research maintains its "speculative buy" rating and a price target of $0.50, which implies 82% upside, after the company released its quarterly earnings report."